Article
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Nature - 1 May 2008
Mullighan Charles G, Miller Christopher B, Radtke Ina, Phillips Letha A, Dalton James, Ma Jing, White Deborah, Hughes Timothy P, Le Beau Michelle M, Pui Ching-Hon, Relling Mary V, Shurtleff Sheila A, Downing James R
Abstract excerpt
The Philadelphia chromosome, a chromosomal abnormality that encodes BCR-ABL1, is the defining lesion of chronic myelogenous leukaemia (CML) and a subset of acute lymphoblastic leukaemia (ALL). To define oncogenic lesions that cooperate with BCR-ABL1 to induce ALL, we performed a genome-wide analysis of diagnostic leukaemia samples from 304 individuals with ALL, including 43 BCR-ABL1 B-progenitor ALLs and 23 CML...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
